556 related articles for article (PubMed ID: 38239190)
1. Current trends and future prospects of drug repositioning in gastrointestinal oncology.
Fatemi N; Karimpour M; Bahrami H; Zali MR; Chaleshi V; Riccio A; Nazemalhosseini-Mojarad E; Totonchi M
Front Pharmacol; 2023; 14():1329244. PubMed ID: 38239190
[TBL] [Abstract][Full Text] [Related]
2. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing: An emerging strategy in alleviating skin cancer.
Kumbhar P; Kole K; Yadav T; Bhavar A; Waghmare P; Bhokare R; Manjappa A; Jha NK; Chellappan DK; Shinde S; Singh SK; Dua K; Salawi A; Disouza J; Patravale V
Eur J Pharmacol; 2022 Jul; 926():175031. PubMed ID: 35580707
[TBL] [Abstract][Full Text] [Related]
6. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
11. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
De Lellis L; Veschi S; Tinari N; Mokini Z; Carradori S; Brocco D; Florio R; Grassadonia A; Cama A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439102
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration.
Li XJ; Nie P; Herdewijn P; Sun JG
Eur J Med Chem; 2023 Dec; 262():115928. PubMed ID: 37944387
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
[TBL] [Abstract][Full Text] [Related]
14. Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers.
Lu Z; Peng Z; Liu C; Wang Z; Wang Y; Jiao X; Li J; Shen L
Innovation (Camb); 2020 Aug; 1(2):100041. PubMed ID: 34557714
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology.
Ribeiro E; Vale N
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759695
[TBL] [Abstract][Full Text] [Related]
18. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer.
Beklen H; Gulfidan G; Arga KY; Mardinoglu A; Turanli B
Front Oncol; 2020; 10():1273. PubMed ID: 32903699
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer.
Kumbhar P; Kole K; Khadake V; Marale P; Manjappa A; Nadaf S; Jadhav R; Patil A; Singh SK; Dua K; Jha NK; Disouza J; Patravale V
J Control Release; 2022 Sep; 349():812-830. PubMed ID: 35914614
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
Ng YL; Salim CK; Chu JJH
Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
